NorthWest Biotherapeutics Inc (NWBO)

[Karlchen]

.The 50% results came when poly iclc was administered directly to patients. Presumably as a drug itself, in those patient’s bloodstreams it did things beyond just the cells that it might have been used to mature if it was used in the formulation of DCVax-L in the main Phase3

. . . . . in the arm of the patient, I'd like to add (as you mentioned before in another post)

my question is:
what does it matter?
if DCVax is approved BY ITSELF
Oncovir / poly ICLC IS STILL APPROVED
and Doctors, as they know the great benefit of combination, administer just both!?

and that CURE will spread all over the world!